Zevra Therapeutics (ZVRA) Property, Plant & Equipment (Net) (2014 - 2026)

Zevra Therapeutics (ZVRA) Property, Plant & Equipment (Net) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Zevra Therapeutics 570.04 Mn 369.43 Mn 34.32 Mn 430,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 430,000.00
Mar 31, 2026 430,000.00
Dec 31, 2025 489,000.00
Dec 31, 2025 489,000.00
Sep 30, 2025 488,000.00
Sep 30, 2025 488,000.00
Jun 30, 2025 599,000.00
Jun 30, 2025 599,000.00
Mar 31, 2025 422,000.00
Mar 31, 2025 422,000.00
Dec 31, 2024 356,000.00
Dec 31, 2024 356,000.00
Sep 30, 2024 607,000.00
Sep 30, 2024 607,000.00
Jun 30, 2024 678,000.00
Jun 30, 2024 678,000.00
Mar 31, 2024 695,000.00
Mar 31, 2024 695,000.00
Dec 31, 2023 736,000.00
Dec 31, 2023 736,000.00